The start of the year is a good time to add to your existing portfolio or start new positions. An excellent source to look for ideas is among the Dogs of the Dow. These stocks are the highest-yielding ones in the Dow Jones Industrial Average (DJIA) at the end of the preceding year. The strategy…

Because Covid-19 has dominated the news cycle for almost two years, many investors have ignored drug stocks outside of that domain. Betting on vaccine suppliers like Moderna (NASDAQ:MRNA) or BioNTech (NASDAQ:BNTX) has paid off — those stocks more than tripled at their peak. Since August, buying interest in these stocks has waned. The drop in…

Since March 16 of last year, the Nasdaq composite has been on a roll, up almost 130%, drawing investors seeking stocks to buy. Every time it seems like that run is over, the index keeps pushing through and continues to hit new record highs. Much of this growth started last year when pandemic-related restrictions led…

Verastem (NASDAQ:VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (NASDAQ:AMGN). Source: Bukhta Yurii / Shutterstock.com Let’s dive into the deal that has VSTM stock on the move today below! The new deal covers a clinical collaboration agreement with Amgen. This will have them working…

One of my favorite InvestorPlace commentators is Josh Enomoto. He tells it like it is while providing a balanced analysis. For example, Enomoto recently discussed seven penny stocks getting lots of attention from the Reddit crowd. One of the names on his list was Atossa Therapeutics (NASDAQ:ATOS) stock. Source: luchschenF / Shutterstock.com Atossa develops novel…

Investing in biotech stocks is not everyone’s cup of tea. A lot of it is because of the volatility that comes with investing in them. The reason for the volatile swings in biotech stocks is that they tend to trade on catalysts. The outcomes of trial data, regulatory approvals, and other company data are crucial…